Spectrum of pulmonary side-effects of nivolumab – retrospective analysis

Autor: Ip, Joana
Jazyk: angličtina
Rok vydání: 2018
Předmět:
DOI: 10.1594/ecr2018/c-0282
Popis: Learning objectives Background Findings and procedure details Conclusion Personal information References
Learning objectives: Nivolumab is a monoclonal antibody (anti PD-1) approvedfor the treatment of advanced melanoma, advanced non-small cell lung cancer (NSCLC), advanced renal cell carcinoma, classical Hodgkin lymphoma, advanced squamous cell carcinoma of the head and...
Databáze: OpenAIRE